chemo-immunotherapy for tnbc
Published 4 years ago • 240 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
1:01
chemo-immunotherapy for tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
1:07
combining 1l chemo-immunotherapy with oleclumab in patients with advanced tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
2:30
impassion130: immunotherapy for tnbc
-
0:37
management for residual disease in tnbc after chemo-immunotherapy
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
1:39
encouraging developments in triple negative breast cancer immunotherapy
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
2:01
ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
-
1:24
combining chemotherapy, cd40 agonist, and flt3 ligand in triple-negative breast cancer
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
2:53
neoadjuvant chemoimmunotherapy: keynote-522, i-spy & more
-
3:28
immunotherapy in early-stage tnbc - where do we stand?